About SYNLAB
SYNLAB is a company based in Munchen (Germany) founded in 1998 was acquired by Cinven in June 2015. The company has 28,693 employees as of December 31, 2022. SYNLAB has completed 11 acquisitions, including Belluno Medica, Cityterveys and Igea Sant Antimo. SYNLAB operates in a competitive market with competitors including Natera, Progenity, Beikang Medical, Yourgene Health and Sequenom, among others.
- Headquarter Munchen, Germany
- Employees 28693 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Synlab International Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.8 M (USD), Grant
Dec 31, 2016
-
Investors
European Union
& 4 more
-
Employee Count
28693
as on Dec 31, 2022
-
Investments & Acquisitions
Belluno Medica
& 10 more
-
Acquired by
Cinven
(Jun 25, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of SYNLAB
Unlock access to complete
Unlock access to complete
Funding Insights of SYNLAB
Investors in SYNLAB
SYNLAB has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, BC Partners and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
Diversified alternative assets are managed through investment strategies.
|
Locked | Locked | Locked |
Investor details for SYNLAB
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SYNLAB
SYNLAB has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Belluno Medica, Cityterveys and Igea Sant Antimo.
Investment portfolio details for SYNLAB
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Standalone general clinic
|
Locked | Locked | 2015 | Locked | |
|
Standalone radiology & pathology laboratory center
|
Locked | Locked | 2015 | Locked | |
|
Limited information available
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for SYNLAB
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SYNLAB
Detailed financials for SYNLAB
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synlab Comparisons
Peer comparison for SYNLAB
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SYNLAB
SYNLAB operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, Progenity, Beikang Medical, Yourgene Health and Sequenom, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genetic tests and genomic services are provided.
|
|
| Locked | Locked | Locked |
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered.
|
Detailed competitors of SYNLAB
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synlab
Complete news archive for SYNLAB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SYNLAB
SYNLAB was founded in 1998 and raised its 1st funding round 11 years after it was founded.
SYNLAB is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Mathieu Floreani is the current CEO of SYNLAB.
As of Dec 31, 2022, the latest employee count at SYNLAB is 28,693.
SYNLAB was founded in 1998 and is headquartered in Munich, Germany. Operations are conducted in the medical diagnostics sector, with a focus on clinical laboratory analysis. Services encompass various diagnostic categories through an advanced network spanning Europe and beyond. A workforce of over 28,000 employees, including medical experts, supports these activities. The company maintains a global presence to serve customer needs in laboratory testing.
SYNLAB's top competitors include Natera, IdentifAI and Beikang Medical.
SYNLAB has made 11 acquisitions, including Belluno Medica, Cityterveys, and Igea Sant Antimo.
SYNLAB has 5 investors. Key investors include European Union, BC Partners, EIC Fund, Novo Holdings, and Cinven.